.
MergerLinks Header Logo

Announced

Completed

Novo Holdings completed the acquisition of BBI Group from Exponent for £400m.

Financials

Edit Data
Transaction Value£400m
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales7x
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

diagnostics products

Private

Friendly

Cross Border

Single Bidder

Majority

Private Equity

Medical Supplies

United Kingdom

Completed

Acquisition

testing inspection and certification

Synopsis

Edit

Novo Holdings, a global life sciences investor, completed the acquisition of BBI Group, a supplier of products and services to the global diagnostics and life sciences industries, from Exponent, a private equity firm, for c.£400m ($564m). "We see tremendous opportunities for both organic and inorganic growth for the company. Novo Holdings is looking forward to contributing its considerable industry expertise and extensive network in supporting the talented team at BBI," Johan Hueffer, Novo Holdings Senior Partner.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US